Craft Brew Alliance (BREW): Stock Hits 52-Week High After New Anheuser-Busch (BUD) Deal
Superman and Stocks: It's Not the Cape (CAPE), It's the Kryptonite (Cash Flow)!
GSV Capital Corp. Announces Adjustment to Conversion Rate of 5.25% Convertible Senior Notes Due 2018
Royalty and Streaming Companies Are a Great Way to Get in on the Gold Bull Run
Celsius (CELH) and Flo Rida Renew Worldwide Agreement
Cameron Reynolds of VolitionRX Ltd. ($VNRX) sits down with Equities.com to discuss the company's blood-based diagnostic tests for cancer.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2016 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).